Group One Trading’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-5,000
Closed -$2K 5553
2015
Q3
$2K Sell
5,000
-100
-2% -$57 ﹤0.01% 4728
2015
Q2
$3K Buy
+5,100
New +$3.46K ﹤0.01% 4640
2015
Q1
Sell
-3,000
Closed -$2K 5607
2014
Q4
$2K Sell
3,000
-13,100
-81% -$7.92K ﹤0.01% 4743
2014
Q3
$9K Buy
16,100
+3,500
+28% +$4.43K ﹤0.01% 4535
2014
Q2
$16K Sell
12,600
-7,900
-39% -$11.3K ﹤0.01% 4310
2014
Q1
$37K Sell
20,500
-29,100
-59% -$49.1K ﹤0.01% 3861
2013
Q4
$77K Buy
49,600
+31,600
+176% +$71.2K ﹤0.01% 3274
2013
Q3
$44K Sell
18,000
-40,400
-69% -$112K ﹤0.01% 3643
2013
Q2
$168K Buy
+58,400
New +$162K ﹤0.01% 2338

Other funds holding ONCY

Group One Trading's ONCY Position: Q4 2015 in Review

Group One Trading sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 38,529 shares — an estimated $18K sold.

Group One Trading first reported a position in ONCY in Q2 2013 and held it in 7 quarters. The position peaked at $109K in Q2 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Group One Trading reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Group One Trading sold 38,529 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $18K.
  • Group One Trading first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 7 quarters.
  • Group One Trading's ONCOLYTICS BIOTECH INC position peaked at $109K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Group One Trading's 13F filing for Q4 2015, filed 11 Feb 2016.